Endologix, Inc. (ELGX) - Medical Equipment - Deals and Alliances Profile

Date: July 21, 2016
Pages: 58
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: EE51B81F400EN
Leaflet:

Download PDF Leaflet

Endologix, Inc. (ELGX) - Medical Equipment - Deals and Alliances Profile
Summary

Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). The company’s AAA products are built on traditional minimally-invasive endovascular repair (EVAR) platform or endovascular sealing (EVAS) platform. The company’s EVAR products include AFX endovascular AAA system Vela Proximal Endograft and Intuitrak endovascular AAA system; and EVAS products comprise Nellix endovascular aneurysm sealing system. It has manufacturing facility in Irvine. The company sells its products to hospitals in the US and Europe through direct sales force and through third-party international distributors and agents in other parts of the world. Endologix is headquartered in California, the US.

Endologix, Inc. (ELGX) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Endologix, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Endologix, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Endologix, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Endologix, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Endologix, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Endologix, Inc., Medical Equipment, Deal Details
Venture Financing
TriVascular Raises US$2 Million In Venture Financing
TriVascular Raises US$40 Million In Series E Financing
Trivascular Raises Funds Through Initial Tranche Of Series D Financing
TriVascular Raises US$7.2 Million In Venture Financing
TriVascular Secures US$60 Million In Series C Round Of Financing
Partnerships
Endologix Enters Into An Agreement With Evasc Medical Systems
LeMaitre Vascular Terminates Distribution Agreement With Endologix
Equity Offering
TriVascular Technologies Completes IPO For US$89.7 Million
Endologix Completes Public Offering Of Common Stock For US$40 Million
Endologix Completes Private Placement Of US$15 Million
Debt Offering
Endologix Raises USD125 Million in Public Offering of 3.25% Notes Due 2020
TriVascular Raises USD10 Million in Private Placement
Endologix Completes Public Offering Of Notes Due 2018 For US$86.3 Million
Acquisition
Endologix Acquires TriVascular Technologies
Endologix Completes Acquisition Of Nellix Endovascular
Endologix, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
May 09, 2016: Endologix Reports Results for the First Quarter 2016
Feb 22, 2016: Endologix Reports Results for the Fourth Quarter and Full Year 2015
Oct 26, 2015: Endologix Reports Third Quarter 2015 Financial Results
Aug 03, 2015: Endologix Reports Second Quarter 2015 Financial Results
Apr 29, 2015: Endologix Reports 10% Revenue Growth for the First Quarter 2015
Feb 25, 2015: Endologix Reports 10% and 12% Revenue Growth for the Fourth Quarter and Full Year 2014
Corporate Communications
Sep 17, 2015: Endologix Appoints Vaseem Mahboob as Chief Financial Officer
Apr 29, 2015: Endologix Appoints Leslie Norwalk to Board of Directors
Mar 12, 2015: Endologix Announces Chief Financial Officer Transition
Product News
Mar 08, 2016: Endologix Announces First Patients in Japan Treated With Nellix EndoVascular Aneurysm Sealing System
Feb 29, 2016: Endologix Announces First U.S. Commercial Implant of AFX2 Bifurcated Endograft System
Dec 10, 2015: Endologix AFX Endovascular AAA System Receives Shonin Approval for Marketing in Japan
Apr 29, 2015: Positive Nellix Clinical Data From the EVAS FORWARD Global Registry Presented at the 37th Annual Charing Cross Symposium
Product Approvals
Dec 10, 2015: Endologix AFX Endovascular AAA System Receives Shonin Approval for Marketing in Japan
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Endologix, Inc., Medical Equipment, Key Facts, 2015
Endologix, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Endologix, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Endologix, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Endologix, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Endologix, Inc., Deals By Market, 2010 to YTD 2016
Endologix, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
TriVascular Raises US$2 Million In Venture Financing
TriVascular Raises US$40 Million In Series E Financing
Trivascular Raises Funds Through Initial Tranche Of Series D Financing
TriVascular Raises US$7.2 Million In Venture Financing
TriVascular Secures US$60 Million In Series C Round Of Financing
Endologix Enters Into An Agreement With Evasc Medical Systems
LeMaitre Vascular Terminates Distribution Agreement With Endologix
TriVascular Technologies Completes IPO For US$89.7 Million
Endologix Completes Public Offering Of Common Stock For US$40 Million
Endologix Completes Private Placement Of US$15 Million
Endologix Raises USD125 Million in Public Offering of 3.25% Notes Due 2020
TriVascular Raises USD10 Million in Private Placement
Endologix Completes Public Offering Of Notes Due 2018 For US$86.3 Million
Endologix Acquires TriVascular Technologies
Endologix Completes Acquisition Of Nellix Endovascular
Endologix, Inc., Key Competitors
Endologix, Inc., Key Employees
Endologix, Inc., Subsidiaries

LIST OF FIGURES

Endologix, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Endologix, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Endologix, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Endologix, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Endologix, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Endologix, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Endologix, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Endologix, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Endologix, Inc. (ELGX) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: